Form 8-K - Current report:
SEC Accession No. 0000950123-06-003872
Filing Date
2006-03-29
Accepted
2006-03-29 17:15:58
Documents
3
Period of Report
2006-03-24
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y19229e8vk.htm 8-K 14743
2 EX-99.1: PRESS RELEASE y19229exv99w1.htm EX-99.1 7143
3 GRAPHIC y19229y1922900.gif GRAPHIC 3308
  Complete submission text file 0000950123-06-003872.txt   28232
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 06719727
SIC: 2835 In Vitro & In Vivo Diagnostic Substances